Engerix-b 20 MCG/ML syrnml
Ended Awarded
- Contract number
- SPE2D325F289R
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $7,878
Award facts
- Contract value 100% obligated
- $7,878.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,878.00 by the Defense Logistics Agency's Medical Supply Chain on August 5, 2025, for the supply of ENGERIX-B 20 MCG/ML syringes. This firm fixed-price delivery order, which carries an ultimate completion date of August 8, 2025, represents a discrete procurement action under the company's existing Indefinite Delivery Contract with DLA. The award carries no set-aside designation, reflecting DMS Pharmaceutical Group's competitive positioning as an established federal pharmaceutical supplier. Performance will be executed at the company's Park Ridge, Illinois facility.
This delivery order exemplifies DMS Pharmaceutical Group's core operational focus as a critical supplier within the federal pharmaceutical supply chain, particularly for the Department of Defense healthcare system. The company maintains a substantial single-award IDC with DLA valued at approximately $500 million through November 2026, which authorizes the issuance of delivery orders for a comprehensive portfolio of pharmaceutical products serving military health facilities nationwide. DMS Pharmaceutical Group's extensive contract history demonstrates sustained capability in providing vaccines, biologics, and specialized pharmaceutical products to federal agencies, establishing it as a reliable vendor for urgent medical supply requirements across the defense healthcare infrastructure.
Quick answers
Who was awarded contract SPE2D325F289R?
SPE2D325F289R was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 5, 2025.
How much is contract SPE2D325F289R worth?
The government has obligated $7,878 on SPE2D325F289R.
Is contract SPE2D325F289R an order under another contract?
Yes. SPE2D325F289R is a delivery order under SPE2D021DA002, an indefinite delivery contract.
Was contract SPE2D325F289R competed?
The extent of competition for SPE2D325F289R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award